Skip to contents

  1. Ryzhikov, A. B.; Ryzhikov, Е. А.; Bogryantseva, M. P.; Usova, S. V.; Danilenko, E. D.; Nechaeva, E. A.; Pyankov, O. V.; Pyankova, O. G.; Gudymo, A. S.; Bodnev, S. A.; Onkhonova, G. S.; Sleptsova, E. S.; Kuzubov, V. I.; Ryndyuk, N. N.; Ginko, Z. I.; Petrov, V. N.; Moiseeva, A. A.; Torzhkova, P. Yu.; Pyankov, S. A.; Tregubchak, T. V.; Antonec, D. V.; Gavrilova, E. V.; Maksyutov, R. A.

    A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    SPb RAACI, 2021

    Published in: Russian Journal of Infection and Immunity, 11 (2021) 2, Seite 283-296